ArticleGynecologic oncology reports2026
Rare case of primary HPV negative vaginal cancer presenting in a young woman with normal cervix.
Article in Gynecologic oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary vaginal cancer is defined as malignancy of the vaginal wall without coexisting cervical or vulvar pathology or history of such in the past 5 years. It is a rare diagnosis, and makes up only 1-3% of all gynecologic cancer globally. Major risk factors historically have included older age, history of high-risk HPV infection, diethylstilbestrol (DES) exposure, immunocompromise, history of tobacco smoking (Adams et al., 2025, Di Donato et al., 2012). Case presentation: A healthy 32-year-old women, with well documented history of normal Pap smears presented with primary, HPV negative, invasive squamous cell carcinoma of the vagina. The patient was diagnosed via tissue biopsy and treated successfully according to standard chemoradiation protocol for primary vaginal cancer, despite rare presentation. The patient remains disease free at 22 months and avoided vaginectomy to preserve sexual function. Conclusions: This case emphasizes the importance of tissue biopsy for suspicious vaginal lesions, even in the absence of major risk factors for malignancy, as well as the potential broad application of standard chemoradiation in atypical presentations of primary invasive squamous cell vaginal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.